乳房再建市場：製品（乳房インプラント、Tissue Expander、Acellular Dermal Matrix）、施術（即時、遅延、修正）、タイプ（片側、両側）、エンドユーザー（病院、美容クリニック）別 - 2026年までの世界市場予測

Breast Reconstruction Market by Product (Breast implant, Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospitals, Cosmetology Clinics) - Global Forecast to 2026

乳房再建の世界市場規模は、2021年の567百万米ドルから2026年には647百万米ドルに達すると予測され、年平均成長率は2.7%です。この業界の成長は、乳がんの罹患率の上昇、意識の高まり、払い戻しが可能であること... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2022年3月11日	US$4,950 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	241	337	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

乳房再建の世界市場規模は、2021年の567百万米ドルから2026年には647百万米ドルに達すると予測され、年平均成長率は2.7%です。この業界の成長は、乳がんの罹患率の上昇、意識の高まり、払い戻しが可能であることなどが要因となっています。しかし、乳房再建に伴う臨床リスクや合併症が市場の成長を抑制しています。
"アセラーダーマルマトリックスセグメントは、予測期間中に最も速い成長率で成長すると予想されます。"
乳房再建市場は、製品別に、乳房インプラント、組織拡張器、アセキュラーダーマルマトリックスに分類されます。アセキュラーダーマルマトリックスセグメントは、予測期間中に最も高いCAGRを記録すると予想されます。このセグメントの成長は、主に乳がんの発生率の上昇、乳房切除術の増加、アセキュラーダーマルマトリックスの使用量の増加によってもたらされています。
"即時処置セグメントは、予測期間中に急速な速度で成長すると推定される。"
乳房再建市場は、術式に基づき、即時術式、遅延術式、再手術に区分されます。即時処置は、乳房再建期間中、世界の乳房再建市場で最も急成長するセグメントであり続けると予想されます。乳房切除後の手術件数の増加や認知度の上昇などの要因が市場を牽引しています。
"アジア太平洋地域は調査期間中に最も高いCAGRを記録すると推定される。"
地域的には、乳房再建市場は北米とヨーロッパが支配しています。しかし、アジア太平洋地域の市場は、予測期間中に最も速い速度で成長すると推定されます。
主要参加者のプロフィールの内訳
- 企業タイプ別。Tier1：32％、Tier2：44％、Tier3：24％。
- 役職別Cレベル：30％、ディレクターレベル：34％、その他。36%
- 地域別北米：40％、欧州：28％、アジア太平洋：20％、その他の地域：12

乳房再建市場の主要プレイヤーは、Mentor Worldwide LLC (Johnson & Johnson) （米国）、Allergan Aesthetics (An AbbVie Company) （米国）、Ideal Implant Incorporated （米国）、Sebin （フランス）、GC Aesthetics （アイルランド）、POLYTECH Health & Aesthetics （ドイツ）、Sientra （米国）等です。

調査対象。
本レポートでは、乳房再建市場を製品、手順、タイプ、エンドユーザー、地域別に分析しています。包括的な地理的製品分析および市場規模の算出とは別に、過去3年間に市場プレイヤーが採用した成長戦略を網羅した競争環境も提供しています。さらに、企業プロフィールには、製品ポートフォリオ、開発、市場シェアを維持・拡大するために著名な市場プレーヤーが採用した戦略などが記載されています。市場調査データ、現在の市場規模、将来動向の予測は、主要な市場参加者や新規参入者が市場で成功を収めるために、製品提供、地域的フォーカス、戦略的アプローチの変更、生産レベルに関して必要な意思決定を行うのに役立ちます。
レポート購入の主なメリット
本レポートは、既存企業、新規参入企業、中小企業のいずれもが市場の動向を把握することができ、ひいてはこれらの企業がより大きな市場シェアを獲得するのに役立つものです。本レポートを購入された企業は、以下の5つの戦略のいずれか、または組み合わせて、市場シェアの強化に役立てることができます。
本レポートでは、以下のポイントについて考察しています。
- 市場浸透度。乳房再建市場におけるトッププレイヤーの製品に関する包括的な情報
- 競合の評価。乳房再建市場における主要企業の市場戦略、地域別・事業別セグメント、製品ポートフォリオに関する詳細な評価
- 市場の発展新興国市場に関する詳細情報
- 市場の多様化。乳房再建市場における新製品、未開拓の地域、最近の開発、投資に関する徹底的な情報提供

ページTOPに戻る

Table of Contents

Summary

The global breast reconstruction market size is projected to reach USD 647 million by 2026 from USD 567 million in 2021, at a CAGR of 2.7%. Growth in this industry is driven by the rising incidences of breast cancer, increasing awareness, and the availability of reimbursements. However, clinical risks and complications associated with breast reconstruction restrain the market growth.
“The acellular dermal matrix segment is anticipated to grow at the fastest growth rate during the forecast period.”
The breast reconstruction market, by product, is categorized into breast implants, tissue expanders, and acellular dermal matrix. The acellular dermal matrix segment is expected to register the highest CAGR during the forecast period. The growth of this segment is mainly driven by the rising incidences of breast cancer, increasing number of mastectomies, and growing use usage of acellular dermal matrices.
“The immediate procedure segment is estimated to grow at a rapid rate during the forecast period.”
On the basis of procedure, the breast reconstruction market is segmented into immediate, delayed, and revision procedures. Immediate procedures are expected to remain the fastest-growing segment of the global breast reconstruction market during the breast reconstruction period. Factors such as the increasing number of surgeries post-mastectomy and rising awareness are driving the market.
“Asia Pacific is estimated to register the highest CAGR during the study period.”
Geographically, the breast reconstruction market is dominated by North America and Europe. However, the Asia Pacific market is estimated to grow at the fastest rate during the forecast period.
Breakdown of Profiles of Primary Participants:
• By Company Type: Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
• By Designation: C-level: 30%, Director-level: 34%, and Others: 36%
• By Region: North America: 40%, Europe: 28%, Asia Pacific: 20%, and the Rest of the World: 12%

The key players in the breast reconstruction market include Mentor Worldwide LLC (Johnson & Johnson) (US), Allergan Aesthetics (An AbbVie Company) (US), Ideal Implant Incorporated (US), Sebbin (France), GC Aesthetics (Ireland), POLYTECH Health & Aesthetics (Germany), and Sientra (US).

Research Coverage:
The report analyzes the breast reconstruction market by product, procedure, type, end user, and region. Apart from comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by market players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, changes in strategic approach, and levels of output to remain successful in the market.
Key Benefits of Buying the Report:
This report will enable both established firms and new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use either or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the products of the top players in the breast reconstruction market
• Competitive Assessment: In-depth assessment of market strategies, geographic and business segments, and product portfolios of the leading players in the breast reconstruction market
• Market Development: Detailed information about emerging markets
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the breast reconstruction market

ページTOPに戻る

1 INTRODUCTION 37

1.1 OBJECTIVES OF THE STUDY 37

1.2 MARKET DEFINITION 37

1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 38

1.3 MARKET SCOPE 38

1.3.1 MARKETS COVERED 38

1.3.2 YEARS CONSIDERED FOR THE STUDY 39

1.4 CURRENCY 39

TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD 39

1.5 LIMITATIONS 40

1.6 STAKEHOLDERS 40

1.7 SUMMARY OF CHANGES 40

2 RESEARCH METHODOLOGY 42

2.1 RESEARCH DATA 42

FIGURE 1 RESEARCH DESIGN 42

2.1.1 SECONDARY DATA 43

2.1.1.1 Secondary sources 44

2.1.2 PRIMARY DATA 44

FIGURE 2 PRIMARY SOURCES 45

2.1.2.1 Key data from primary sources 46

2.1.2.2 Key industry insights 47

2.1.2.3 Breakdown of primary interviews: By company type,

designation, and region 47

2.2 MARKET SIZE ESTIMATION 48

FIGURE 3 REVENUE SHARE ANALYSIS ILLUSTRATION: SIENTRA. 48

FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF BREAST RECONSTRUCTION PRODUCTS AND SERVICES 49

FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 50

FIGURE 6 TOP-DOWN APPROACH 51

2.3 MARKET BREAKDOWN & DATA TRIANGULATION 52

FIGURE 7 DATA TRIANGULATION METHODOLOGY 52

2.4 MARKET SHARE ANALYSIS 53

2.5 ASSUMPTIONS FOR THE STUDY 53

2.6 LIMITATIONS 53

2.6.1 METHODOLOGY-RELATED LIMITATIONS 53

2.7 RISK ASSESSMENT 54

TABLE 2 RISK ASSESSMENT: BREAST RECONSTRUCTION MARKET 54

2.8 COVID-19 HEALTH ASSESSMENT 54

2.9 COVID-19 ECONOMIC ASSESSMENT 55

2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 55

FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY 55

FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 57

3 EXECUTIVE SUMMARY 58

FIGURE 10 BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2021 VS. 2026 (USD MILLION) 58

FIGURE 11 BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2021 VS. 2026 (USD MILLION) 59

FIGURE 12 BREAST RECONSTRUCTION MARKET, BY TYPE,

2021 VS. 2026 (USD MILLION) 59

FIGURE 13 BREAST RECONSTRUCTION MARKET, BY END USER,

2021 VS. 2026 (USD MILLION) 60

FIGURE 14 BREAST RECONSTRUCTION MARKET, BY REGION,

2021 VS. 2026 (USD MILLION) 61

4 PREMIUM INSIGHTS 62

4.1 BREAST RECONSTRUCTION MARKET OVERVIEW 62

FIGURE 15 RISING INCIDENCES OF BREAST CANCER EXPECTED TO DRIVE THE GROWTH OF THE MARKET DURING THE FORECAST PERIOD 62

4.2 BREAST RECONSTRUCTION BREAST IMPLANTS MARKET, BY TYPE,

2021 VS. 2026 (USD MILLION) 63

FIGURE 16 SILICONE IMPLANT SEGMENT TO GROW AT A CAGR

DURING HE FORECAST PERIOD 63

4.3 NORTH AMERICA: BREAST RECONSTRUCTION MARKET,

BY PRODUCT AND COUNTRY (2020) 63

FIGURE 17 BREAST IMPLANTS ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020 63

4.4 BREAST RECONSTRUCTION MARKET, BY PROCEDURE, 2021–2026 64

FIGURE 18 IMMEDIATE PROCEDURE SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2021-2026) 64

4.5 BREAST RECONSTRUCTION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 65

FIGURE 19 THE BREAST RECONSTRUCTION MARKET IN CHINA EXPECTED TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 65

5 MARKET OVERVIEW 66

5.1 INTRODUCTION 66

5.2 MARKET DYNAMICS 66

FIGURE 20 BREAST RECONSTRUCTION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 66

5.2.1 DRIVERS 67

5.2.1.1 Increasing incidence of breast cancer 67

TABLE 3 TOP 10 COUNTRIES WITH THE HIGHEST INCIDENCE OF

BREAST CANCER, 2020 67

TABLE 4 INCIDENCE OF BREAST CANCER, 2018 VS. 2020 VS. 2025 68

5.2.1.2 Growing aging population 68

5.2.1.3 Increasing awareness regarding breast reconstruction treatment 68

5.2.1.4 Improving reimbursements for breast reconstruction procedures 69

TABLE 5 CPT CODES FOR BREAST RECONSTRUCTION 69

5.2.2 RESTRAINTS 70

5.2.2.1 Clinical risks and complications of breast reconstruction procedures 70

5.2.2.2 Alternative non-surgical methods 70

5.2.3 OPPORTUNITIES 70

5.2.4 HIGH MARKET GROWTH POTENTIAL IN EMERGING ECONOMIES 70

5.2.4.1 Development of 3D-printed implants 71

5.2.4.2 Rise in preference for biological products 71

5.2.5 CHALLENGES 72

5.2.5.1 Product failures and recalls 72

5.2.5.2 Dearth of trained professionals 72

5.2.6 COVID-19 IMPACT ON THE BREAST RECONSTRUCTION MARKET 72

5.3 RANGES/SCENARIOS 73

5.3.1 BREAST RECONSTRUCTION MARKET 73

FIGURE 21 PESSIMISTIC SCENARIO 73

FIGURE 22 OPTIMISTIC SCENARIO 74

FIGURE 23 REALISTIC SCENARIO 74

5.4 TARIFF AND REGULATORY LANDSCAPE 75

5.4.1 NORTH AMERICA 75

5.4.1.1 US 75

TABLE 6 US FDA: MEDICAL DEVICE CLASSIFICATION 75

TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 76

5.4.1.2 Canada 76

TABLE 8 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 76

TABLE 9 BREAST LESION LOCALIZATION DEVICES CLASSIFICATION ACCORDING TO THE GOVERNMENT OF CANADA 77

5.4.2 EUROPE 77

FIGURE 24 EUROPE: CLASS III MEDICAL DEVICES 77

5.4.3 ASIA PACIFIC 78

5.4.3.1 Japan 78

TABLE 10 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY 78

5.4.3.2 China 78

TABLE 11 NMPA MEDICAL DEVICES CLASSIFICATION 79

5.4.3.3 India 79

5.5 PORTER’S FIVE FORCES ANALYSIS 79

TABLE 12 BREAST RECONSTRUCTION MARKET: PORTER’S FIVE FORCES ANALYSIS 79

5.5.1 INTENSITY OF COMPETITIVE RIVALRY 80

5.5.2 BARGAINING POWER OF SUPPLIERS 80

5.5.3 BARGAINING POWER OF BUYERS 80

5.5.4 THREAT OF SUBSTITUTES 80

5.5.5 THREAT OF NEW ENTRANTS 80

5.6 TECHNOLOGY ANALYSIS 81

5.7 VALUE CHAIN ANALYSIS 82

FIGURE 25 VALUE CHAIN ANALYSIS FOR THE BREAST RECONSTRUCTION MARKET 82

5.8 SUPPLY CHAIN ANALYSIS 82

FIGURE 26 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES 83

5.9 PATENT ANALYSIS 84

5.9.1 PATENT GRANTED TRENDS FOR BREAST RECONSTRUCTION 84

FIGURE 27 PATENT GRANTED TRENDS OF BREAST IMPLANTS,

JANUARY 2011–FEBRUARY 2022 84

FIGURE 28 PATENT GRANTED TRENDS OF ACELLULAR DERMAL MATRIX,

JANUARY 2011– FEBRUARY 2022 85

5.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS 85

FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR BREAST IMPLANTS PATENTS, JANUARY 2011—FEBRUARY 2022 86

FIGURE 30 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ACELLULAR DERMAL MATRIX, JANUARY 2011—FEBRUARY 2022 86

5.10 TRADE ANALYSIS 87

TABLE 13 IMPORT DATA FOR HS CODE 902190 - ARTICLES AND APPLIANCES, WHICH ARE WORN OR CARRIED, OR IMPLANTED IN THE BODY, TO COMPENSATE FOR A DEFECT OR DISABILITY (EXCLUDING ARTIFICIAL PARTS OF THE BODY, COMPLETE HEARING AIDS, AND COMPLETE PACEMAKERS FOR STIMULATING HEART MUSCLES), BY COUNTRY, 2016–2020 (USD MILLION) 87

TABLE 14 EXPORT DATA FOR HS CODE 902190 - ARTICLES AND APPLIANCES, WHICH ARE WORN OR CARRIED, OR IMPLANTED IN THE BODY, TO COMPENSATE FOR A DEFECT OR DISABILITY (EXCLUDING ARTIFICIAL PARTS OF THE BODY, COMPLETE HEARING AIDS, AND COMPLETE PACEMAKERS FOR STIMULATING HEART MUSCLES), BY COUNTRY, 2016–2020 (USD MILLION) 88

5.11 PRICING ANALYSIS 88

TABLE 15 PRICE OF BREAST RECONSTRUCTION PRODUCTS (USD) 88

TABLE 16 AVERAGE COST OF BREAST RECONSTRUCTION SURGERY

USING IMPLANTS (USD) 88

5.12 KEY CONFERENCES & EVENTS IN 2022-2023 89

TABLE 17 BREAST RECONSTRUCTION MARKET: DETAILED LIST OF CONFERENCES & EVENTS 89

5.13 ECOSYSTEM ANALYSIS 91

FIGURE 31 ECOSYSTEM OF THE BREAST HEALTH INDUSTRY 91

5.13.1 ROLE IN THE ECOSYSTEM 92

FIGURE 32 KEY PLAYERS IN THE BREAST RECONSTRUCTION ECOSYSTEM 93

5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 94

5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR BREAST RECONSTRUCTION PRODUCTS MANUFACTURERS OR SERVICE PROVIDERS 94

FIGURE 33 REVENUE SHIFT FOR BREAST RECONSTRUCTION PRODUCTS 94

6 BREAST RECONSTRUCTION MARKET, BY PRODUCT 95

6.1 INTRODUCTION 96

TABLE 18 US: PRODUCTS USED FOR BREAST RECONSTRUCTION PROCEDURES, 2020 96

TABLE 19 BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2018–2020 (USD MILLION) 96

TABLE 20 BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 96

6.2 BREAST IMPLANT 97

TABLE 21 US: TYPES OF BREAST IMPLANTS USED FOR BREAST RECONSTRUCTION PROCEDURES, 2020 97

TABLE 22 BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANT, BY REGION, 2018–2020 (USD MILLION) 97

TABLE 23 BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANT, BY REGION, 2021–2026 (USD MILLION) 98

6.2.1 BREAST IMPLANTS MARKET, BY TYPE 98

TABLE 24 BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANT, BY TYPE,

2018–2020 (USD MILLION) 98

TABLE 25 BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANT, BY TYPE,

2021–2026 (USD MILLION) 98

6.2.1.1 Silicone implants 99

6.2.1.1.1 Silicone breast implants expected to dominate the breast implants market due to their benefits 99

TABLE 26 SILICONE BREAST IMPLANTS MARKET, BY REGION,

2018–2020 (USD MILLION) 99

TABLE 27 SILICONE BREAST IMPLANTS MARKET, BY REGION,

2021–2026 (USD MILLION) 99

6.2.1.2 Saline Implants 100

6.2.1.2.1 Low cost of implants to drive market growth 100

TABLE 28 SALINE IMPLANTS MARKET, BY REGION, 2018–2020 (USD MILLION) 100

TABLE 29 SALINE IMPLANTS MARKET, BY REGION, 2021–2026 (USD MILLION) 100

6.2.2 BREAST IMPLANTS MARKET, BY SHAPE 101

TABLE 30 BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION) 101

TABLE 31 BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION) 101

6.2.2.1 Round implants 101

6.2.2.1.1 Round implants show the highest end-user demand and market growth 101

TABLE 32 ROUND BREAST IMPLANT MARKET, BY REGION, 2018–2020 (USD MILLION) 102

TABLE 33 ROUND BREAST IMPLANT MARKET, BY REGION, 2021–2026 (USD MILLION) 102

6.2.2.2 Anatomical implants 102

6.2.2.2.1 Increasing implant-based breast reconstruction procedures will support the market growth 102

TABLE 34 ANATOMICAL BREAST IMPLANT MARKET, BY REGION,

2018–2020 (USD MILLION) 103

TABLE 35 ANATOMICAL BREAST IMPLANT MARKET, BY REGION,

2021–2026 (USD MILLION) 103

6.3 TISSUE EXPANDER 103

6.3.1 RISING NUMBER OF BREAST RECONSTRUCTION PROCEDURES WILL SUPPORT MARKET GROWTH 103

TABLE 36 BREAST RECONSTRUCTION MARKET FOR TISSUE EXPANDER, BY REGION, 2018–2020 (USD MILLION) 104

TABLE 37 BREAST RECONSTRUCTION MARKET FOR TISSUE EXPANDER, BY REGION, 2021–2026 (USD MILLION) 104

6.4 ACELLULAR DERMAL MATRIX 104

6.4.1 RISING NUMBER OF ACELLULAR DERMAL MATRIX BREAST RECONSTRUCTION PROCEDURES WILL SUPPORT MARKET GROWTH 104

TABLE 38 BREAST RECONSTRUCTION MARKET FOR ACELLULAR DERMAL MATRIX,

BY REGION, 2018–2020 (USD MILLION) 105

TABLE 39 BREAST RECONSTRUCTION MARKET FOR ACELLULAR DERMAL MATRIX,

BY REGION, 2021–2026 (USD MILLION) 105

7 BREAST RECONSTRUCTION MARKET, BY PROCEDURE 106

7.1 INTRODUCTION 107

TABLE 40 US: IMMEDIATE AND DELAYED BREAST RECONSTRUCTION PROCEDURES PERFORMED, 2020 107

TABLE 41 BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2018–2020 (USD MILLION) 107

TABLE 42 BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2021–2026 (USD MILLION) 107

7.2 IMMEDIATE PROCEDURES 108

7.2.1 IMMEDIATE PROCEDURES WAS THE LARGEST MARKET SEGMENT 108

TABLE 43 IMMEDIATE BREAST RECONSTRUCTION PROCEDURES MARKET,

BY REGION, 2018–2020 (USD MILLION) 108

TABLE 44 IMMEDIATE BREAST RECONSTRUCTION PROCEDURES MARKET,

BY REGION, 2021–2026 (USD MILLION) 109

7.3 DELAYED PROCEDURES 109

7.3.1 RISING AWARENESS WILL SUPPORT MARKET GROWTH 109

TABLE 45 DELAYED BREAST RECONSTRUCTION PROCEDURES MARKET, BY REGION, 2018–2020 (USD MILLION) 109

TABLE 46 DELAYED BREAST RECONSTRUCTION PROCEDURES MARKET, BY REGION, 2021–2026 (USD MILLION) 110

7.4 REVISION PROCEDURES 110

7.4.1 DISSATISFACTION AND AESTHETIC ISSUES DRIVE DEMAND FOR REVISION 110

TABLE 47 REVISION BREAST RECONSTRUCTION PROCEDURES MARKET, BY REGION, 2018–2020 (USD MILLION) 110

TABLE 48 REVISION BREAST RECONSTRUCTION PROCEDURES MARKET, BY REGION, 2021–2026 (USD MILLION) 111

8 BREAST RECONSTRUCTION MARKET, BY TYPE 112

8.1 INTRODUCTION 113

TABLE 49 US: UNILATERAL AND BILATERAL BREAST RECONSTRUCTION PROCEDURES PERFORMED, 2020 113

TABLE 50 BREAST RECONSTRUCTION MARKET, BY TYPE, 2018–2020 (USD MILLION) 113

TABLE 51 BREAST RECONSTRUCTION MARKET, BY TYPE, 2021–2026 (USD MILLION) 113

8.2 UNILATERAL BREAST RECONSTRUCTION 114

8.2.1 UNILATERAL RECONSTRUCTION DOMINATES THE MARKET, BY TYPE 114

TABLE 52 UNILATERAL BREAST RECONSTRUCTION MARKET, BY REGION,

2018–2020 (USD MILLION) 114

TABLE 53 UNILATERAL BREAST RECONSTRUCTION MARKET, BY REGION,

2021–2026 (USD MILLION) 114

8.3 BILATERAL 115

8.3.1 APAC TO SHOW HIGHEST GROWTH IN THE MARKET FOR BILATERAL

BREAST RECONSTRUCTION 115

TABLE 54 BILATERAL BREAST RECONSTRUCTION MARKET, BY REGION,

2018–2020 (USD MILLION) 115

TABLE 55 BILATERAL BREAST RECONSTRUCTION MARKET, BY REGION,

2021–2026 (USD MILLION) 115

9 BREAST RECONSTRUCTION MARKET, BY END USER 116

9.1 INTRODUCTION 117

TABLE 56 BREAST RECONSTRUCTION MARKET, BY END USER,

2018–2020 (USD MILLION) 117

TABLE 57 BREAST RECONSTRUCTION MARKET, BY END USER,

2021–2026 (USD MILLION) 117

9.2 HOSPITALS 117

9.2.1 HOSPITALS TO DOMINATE THE BREAST RECONSTRUCTION MARKET DURING THE FORECAST PERIOD 117

TABLE 58 BREAST RECONSTRUCTION MARKET FOR HOSPITALS, BY REGION,

2018–2020 (USD MILLION) 118

TABLE 59 BREAST RECONSTRUCTION MARKET FOR HOSPITALS, BY REGION,

2021–2026 (USD MILLION) 118

9.3 COSMETOLOGY CLINICS & AMBULATORY SURGICAL CENTERS 119

9.3.1 GROWING PREFERENCE FOR OUTPATIENT TREATMENT AND PROCEDURES OVER HOSPITAL CARE DRIVES MARKET GROWTH 119

TABLE 60 BREAST RECONSTRUCTION MARKET FOR COSMETOLOGY CLINICS & AMBULATORY SURGICAL CENTERS, BY REGION, 2018–2020 (USD MILLION) 119

TABLE 61 BREAST RECONSTRUCTION MARKET FOR COSMETOLOGY CLINICS & AMBULATORY SURGICAL CENTERS, BY REGION, 2021–2026 (USD MILLION) 119

9.4 COVID-19 ANALYSIS 120

10 BREAST RECONSTRUCTION MARKET, BY REGION 121

10.1 INTRODUCTION 122

TABLE 62 BREAST RECONSTRUCTION MARKET, BY REGION,

2018–2020 (USD MILLION) 122

TABLE 63 BREAST RECONSTRUCTION MARKET, BY REGION,

2021–2026 (USD MILLION) 122

10.2 NORTH AMERICA 123

FIGURE 34 NORTH AMERICA: BREAST RECONSTRUCTION MARKET SNAPSHOT 124

TABLE 64 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY COUNTRY,

2018–2020 (USD MILLION) 124

TABLE 65 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY COUNTRY,

2021–2026 (USD MILLION) 125

TABLE 66 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2018–2020 (USD MILLION) 125

TABLE 67 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 125

TABLE 68 NORTH AMERICA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION) 126

TABLE 69 NORTH AMERICA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION) 126

TABLE 70 NORTH AMERICA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION) 126

TABLE 71 NORTH AMERICA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION) 127

TABLE 72 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY PROCEDURE, 2018–2020 (USD MILLION) 127

TABLE 73 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY PROCEDURE, 2021–2026 (USD MILLION) 127

TABLE 74 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY TYPE,

2018–2020 (USD MILLION) 128

TABLE 75 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY TYPE,

2021–2026 (USD MILLION) 128

TABLE 76 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY END USER,

2018–2020 (USD MILLION) 128

TABLE 77 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY END USER,

2021–2026 (USD MILLION) 129

10.2.1 US 129

10.2.1.1 The US dominates the North American breast reconstruction market 129

TABLE 78 US: BREAST RECONSTRUCTIVE PROCEDURES PERFORMED IN 2020, BY TYPE 130

TABLE 79 US: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2018–2020 (USD MILLION) 130

TABLE 80 US: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 130

TABLE 81 US: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION) 131

TABLE 82 US: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION) 131

TABLE 83 US: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION) 131

TABLE 84 US: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION) 132

TABLE 85 US: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2018–2020 (USD MILLION) 132

TABLE 86 US: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2021–2026 (USD MILLION) 132

TABLE 87 US: BREAST RECONSTRUCTION MARKET, BY TYPE,

2018–2020 (USD MILLION) 133

TABLE 88 US: BREAST RECONSTRUCTION MARKET, BY TYPE,

2021–2026 (USD MILLION) 133

TABLE 89 US: BREAST RECONSTRUCTION MARKET, BY END USER,

2018–2020 (USD MILLION) 133

TABLE 90 US: BREAST RECONSTRUCTION MARKET, BY END USER,

2021–2026 (USD MILLION) 133

10.2.2 CANADA 134

10.2.2.1 Increasing incidence of breast cancer will drive

market growth in Canada 134

TABLE 91 CANADA: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2018–2020 (USD MILLION) 134

TABLE 92 CANADA: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 134

TABLE 93 CANADA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY TYPE, 2018–2020 (USD MILLION) 135

TABLE 94 CANADA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY TYPE, 2021–2026 (USD MILLION) 135

TABLE 95 CANADA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2018–2020 (USD MILLION) 135

TABLE 96 CANADA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2021–2026 (USD MILLION) 136

TABLE 97 CANADA: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2018–2020 (USD MILLION) 136

TABLE 98 CANADA: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2021–2026 (USD MILLION) 136

TABLE 99 CANADA: BREAST RECONSTRUCTION MARKET, BY TYPE,

2018–2020 (USD MILLION) 137

TABLE 100 CANADA: BREAST RECONSTRUCTION MARKET, BY TYPE,

2021–2026 (USD MILLION) 137

TABLE 101 CANADA: BREAST RECONSTRUCTION MARKET, BY END USER,

2018–2020 (USD MILLION) 137

TABLE 102 CANADA: BREAST RECONSTRUCTION MARKET, BY END USER,

2021–2026 (USD MILLION) 138

10.3 EUROPE 138

TABLE 103 INCIDENCE OF BREAST CANCER IN EUROPEAN COUNTRIES, 2020 VS. 2040 138

TABLE 104 MASTECTOMY SURGERIES PERFORMED IN EUROPE, BY COUNTRY, 2019 138

TABLE 105 EUROPE: BREAST RECONSTRUCTION MARKET, BY COUNTRY,

2018–2020 (USD MILLION) 139

TABLE 106 EUROPE: BREAST RECONSTRUCTION MARKET, BY COUNTRY,

2021–2026 (USD MILLION) 139

TABLE 107 EUROPE: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2018–2020 (USD MILLION) 139

TABLE 108 EUROPE: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 140

TABLE 109 EUROPE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY TYPE, 2018–2020 (USD MILLION) 140

TABLE 110 EUROPE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY TYPE, 2021–2026 (USD MILLION) 140

TABLE 111 EUROPE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2018–2020 (USD MILLION) 141

TABLE 112 EUROPE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2021–2026 (USD MILLION) 141

TABLE 113 EUROPE: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2018–2020 (USD MILLION) 141

TABLE 114 EUROPE: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2021–2026 (USD MILLION) 142

TABLE 115 EUROPE: BREAST RECONSTRUCTION MARKET, BY TYPE,

2018–2020 (USD MILLION) 142

TABLE 116 EUROPE: BREAST RECONSTRUCTION MARKET, BY TYPE,

2021–2026 (USD MILLION) 142

TABLE 117 EUROPE: BREAST RECONSTRUCTION MARKET, BY END USER,

2018–2020 (USD MILLION) 143

TABLE 118 EUROPE: BREAST RECONSTRUCTION MARKET, BY END USER,

2021–2026 (USD MILLION) 143

10.3.1 GERMANY 143

10.3.1.1 Germany dominates the European breast reconstruction market 143

TABLE 119 GERMANY: BREAST CANCER INCIDENCE, 2018 VS. 2025 143

TABLE 120 GERMANY: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2018–2020 (USD MILLION) 144

TABLE 121 GERMANY: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 144

TABLE 122 GERMANY: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY TYPE, 2018–2020 (USD MILLION) 144

TABLE 123 GERMANY: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY TYPE, 2021–2026 (USD MILLION) 145

TABLE 124 GERMANY: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2018–2020 (USD MILLION) 145

TABLE 125 GERMANY: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2021–2026 (USD MILLION) 145

TABLE 126 GERMANY: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2018–2020 (USD MILLION) 146

TABLE 127 GERMANY: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2021–2026 (USD MILLION) 146

TABLE 128 GERMANY: BREAST RECONSTRUCTION MARKET, BY TYPE,

2018–2020 (USD MILLION) 146

TABLE 129 GERMANY: BREAST RECONSTRUCTION MARKET, BY TYPE,

2021–2026 (USD MILLION) 147

TABLE 130 GERMANY: BREAST RECONSTRUCTION MARKET, BY END USER,

2018–2020 (USD MILLION) 147

TABLE 131 GERMANY: BREAST RECONSTRUCTION MARKET, BY END USER,

2021–2026 (USD MILLION) 147

10.3.2 FRANCE 147

10.3.2.1 Rising geriatric population will drive market growth 147

TABLE 132 FRANCE: BREAST CANCER INCIDENCE, 2018 VS. 2025 148

TABLE 133 FRANCE: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2018–2020 (USD MILLION) 148

TABLE 134 FRANCE: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 148

TABLE 135 FRANCE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY TYPE, 2018–2020 (USD MILLION) 148

TABLE 136 FRANCE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY TYPE, 2021–2026 (USD MILLION) 149

TABLE 137 FRANCE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2018–2020 (USD MILLION) 149

TABLE 138 FRANCE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2021–2026 (USD MILLION) 149

TABLE 139 FRANCE: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2018–2020 (USD MILLION) 150

TABLE 140 FRANCE: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2021–2026 (USD MILLION) 150

TABLE 141 FRANCE: BREAST RECONSTRUCTION MARKET, BY TYPE,

2018–2020 (USD MILLION) 150

TABLE 142 FRANCE: BREAST RECONSTRUCTION MARKET, BY TYPE,

2021–2026 (USD MILLION) 151

TABLE 143 FRANCE: BREAST RECONSTRUCTION MARKET, BY END USER,

2018–2020 (USD MILLION) 151

TABLE 144 FRANCE: BREAST RECONSTRUCTION MARKET, BY END USER,

2021–2026 (USD MILLION) 151

10.3.3 UK 152

10.3.3.1 Rising incidences of breast cancer will support market growth 152

TABLE 145 UK: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2018–2020 (USD MILLION) 152

TABLE 146 UK: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 152

TABLE 147 UK: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION) 153

TABLE 148 UK: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION) 153

TABLE 149 UK: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION) 153

TABLE 150 UK: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION) 154

TABLE 151 UK: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2018–2020 (USD MILLION) 154

TABLE 152 UK: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2021–2026 (USD MILLION) 154

TABLE 153 UK: BREAST RECONSTRUCTION MARKET, BY TYPE,

2018–2020 (USD MILLION) 155

TABLE 154 UK: BREAST RECONSTRUCTION MARKET, BY TYPE,

2021–2026 (USD MILLION) 155

TABLE 155 UK: BREAST RECONSTRUCTION MARKET, BY END USER,

2018–2020 (USD MILLION) 155

TABLE 156 UK: BREAST RECONSTRUCTION MARKET, BY END USER,

2021–2026 (USD MILLION) 156

10.3.4 ITALY 156

10.3.4.1 Rising geriatric population in Italy to drive the market 156

TABLE 157 ITALY: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2018–2020 (USD MILLION) 156

TABLE 158 ITALY: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 157

TABLE 159 ITALY: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION) 157

TABLE 160 ITALY: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION) 157

TABLE 161 ITALY: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2018–2020 (USD MILLION) 158

TABLE 162 ITALY: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2021–2026 (USD MILLION) 158

TABLE 163 ITALY: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2018–2020 (USD MILLION) 158

TABLE 164 ITALY: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2021–2026 (USD MILLION) 159

TABLE 165 ITALY: BREAST RECONSTRUCTION MARKET, BY TYPE,

2018–2020 (USD MILLION) 159

TABLE 166 ITALY: BREAST RECONSTRUCTION MARKET, BY TYPE,

2021–2026 (USD MILLION) 159

TABLE 167 ITALY: BREAST RECONSTRUCTION MARKET, BY END USER,

2018–2020 (USD MILLION) 159

TABLE 168 ITALY: BREAST RECONSTRUCTION MARKET, BY END USER,

2021–2026 (USD MILLION) 160

10.3.5 SPAIN 160

10.3.5.1 Silicone implants show high acceptance in Spain 160

TABLE 169 SPAIN: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2018–2020 (USD MILLION) 160

TABLE 170 SPAIN: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 161

TABLE 171 SPAIN: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY TYPE, 2018–2020 (USD MILLION) 161

TABLE 172 SPAIN: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY TYPE, 2021–2026 (USD MILLION) 161

TABLE 173 SPAIN: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2018–2020 (USD MILLION) 162

TABLE 174 SPAIN: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2021–2026 (USD MILLION) 162

TABLE 175 SPAIN: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2018–2020 (USD MILLION) 162

TABLE 176 SPAIN: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2021–2026 (USD MILLION) 163

TABLE 177 SPAIN: BREAST RECONSTRUCTION MARKET, BY TYPE,

2018–2020 (USD MILLION) 163

TABLE 178 SPAIN: BREAST RECONSTRUCTION MARKET, BY TYPE,

2021–2026 (USD MILLION) 163

TABLE 179 SPAIN: BREAST RECONSTRUCTION MARKET, BY END USER,

2018–2020 (USD MILLION) 164

TABLE 180 SPAIN: BREAST RECONSTRUCTION MARKET, BY END USER,

2021–2026 (USD MILLION) 164

10.3.6 REST OF EUROPE 164

TABLE 181 ROE: BREAST CANCER INCIDENCE, BY COUNTRY, 2020 VS. 2040 164

TABLE 182 ROE: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2018–2020 (USD MILLION) 165

TABLE 183 ROE: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 165

TABLE 184 ROE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION) 165

TABLE 185 ROE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION) 166

TABLE 186 ROE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2018–2020 (USD MILLION) 166

TABLE 187 ROE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2021–2026 (USD MILLION) 166

TABLE 188 ROE: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2018–2020 (USD MILLION) 167

TABLE 189 ROE: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2021–2026 (USD MILLION) 167

TABLE 190 ROE: BREAST RECONSTRUCTION MARKET, BY TYPE,

2018–2020 (USD MILLION) 167

TABLE 191 ROE: BREAST RECONSTRUCTION MARKET, BY TYPE,

2021–2026 (USD MILLION) 168

TABLE 192 ROE: BREAST RECONSTRUCTION MARKET, BY END USER,

2018–2020 (USD MILLION) 168

TABLE 193 ROE: BREAST RECONSTRUCTION MARKET, BY END USER,

2021–2026 (USD MILLION) 168

10.4 ASIA PACIFIC 169

FIGURE 35 ASIA PACIFIC: BREAST RECONSTRUCTION MARKET SNAPSHOT 170

TABLE 194 APAC: BREAST RECONSTRUCTION MARKET, BY COUNTRY,

2018–2020 (USD MILLION) 170

TABLE 195 APAC: BREAST RECONSTRUCTION MARKET, BY COUNTRY,

2021–2026 (USD MILLION) 171

TABLE 196 APAC: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2018–2020 (USD MILLION) 171

TABLE 197 APAC: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 171

TABLE 198 APAC: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY TYPE, 2018–2020 (USD MILLION) 172

TABLE 199 APAC: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY TYPE, 2021–2026 (USD MILLION) 172

TABLE 200 APAC: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2018–2020 (USD MILLION) 172

TABLE 201 APAC: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2021–2026 (USD MILLION) 173

TABLE 202 APAC: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2018–2020 (USD MILLION) 173

TABLE 203 APAC: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2021–2026 (USD MILLION) 173

TABLE 204 APAC: BREAST RECONSTRUCTION MARKET, BY TYPE,

2018–2020 (USD MILLION) 174

TABLE 205 APAC: BREAST RECONSTRUCTION MARKET, BY TYPE,

2021–2026 (USD MILLION) 174

TABLE 206 APAC: BREAST RECONSTRUCTION MARKET, BY END USER,

2018–2020 (USD MILLION) 174

TABLE 207 APAC: BREAST RECONSTRUCTION MARKET, BY END USER,

2021–2026 (USD MILLION) 175

10.4.1 CHINA 175

10.4.1.1 China accounts for the largest share of the APAC market 175

TABLE 208 CHINA: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2018–2020 (USD MILLION) 175

TABLE 209 CHINA: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 176

TABLE 210 CHINA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY TYPE, 2018–2020 (USD MILLION) 176

TABLE 211 CHINA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY TYPE, 2021–2026 (USD MILLION) 176

TABLE 212 CHINA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2018–2020 (USD MILLION) 177

TABLE 213 CHINA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2021–2026 (USD MILLION) 177

TABLE 214 CHINA: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2018–2020 (USD MILLION) 177

TABLE 215 CHINA: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2021–2026 (USD MILLION) 178

TABLE 216 CHINA: BREAST RECONSTRUCTION MARKET, BY TYPE,

2018–2020 (USD MILLION) 178

TABLE 217 CHINA: BREAST RECONSTRUCTION MARKET, BY TYPE,

2021–2026 (USD MILLION) 178

TABLE 218 CHINA: BREAST RECONSTRUCTION MARKET, BY END USER,

2018–2020 (USD MILLION) 179

TABLE 219 CHINA: BREAST RECONSTRUCTION MARKET, BY END USER,

2021–2026 (USD MILLION) 179

10.4.2 JAPAN 179

10.4.2.1 Growing awareness of cosmetic surgery to drive the market in Japan 179

TABLE 220 JAPAN: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2018–2020 (USD MILLION) 180

TABLE 221 JAPAN: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 180

TABLE 222 JAPAN: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY TYPE, 2018–2020 (USD MILLION) 180

TABLE 223 JAPAN: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY TYPE, 2021–2026 (USD MILLION) 181

TABLE 224 JAPAN: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2018–2020 (USD MILLION) 181

TABLE 225 JAPAN: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2021–2026 (USD MILLION) 181

TABLE 226 JAPAN: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2018–2020 (USD MILLION) 182

TABLE 227 JAPAN: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2021–2026 (USD MILLION) 182

TABLE 228 JAPAN: BREAST RECONSTRUCTION MARKET, BY TYPE,

2018–2020 (USD MILLION) 182

TABLE 229 JAPAN: BREAST RECONSTRUCTION MARKET, BY TYPE,

2021–2026 (USD MILLION) 183

TABLE 230 JAPAN: BREAST RECONSTRUCTION MARKET, BY END USER,

2018–2020 (USD MILLION) 183

TABLE 231 JAPAN: BREAST RECONSTRUCTION MARKET, BY END USER,

2021–2026 (USD MILLION) 183

10.4.3 INDIA 184

10.4.3.1 Market growth in India is primarily driven by the rising incidence of breast cancer 184

TABLE 232 INDIA: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2018–2020 (USD MILLION) 184

TABLE 233 INDIA: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 184

TABLE 234 INDIA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY TYPE, 2018–2020 (USD MILLION) 185

TABLE 235 INDIA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY TYPE, 2021–2026 (USD MILLION) 185

TABLE 236 INDIA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2018–2020 (USD MILLION) 185

TABLE 237 INDIA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2021–2026 (USD MILLION) 186

TABLE 238 INDIA: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2018–2020 (USD MILLION) 186

TABLE 239 INDIA: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2021–2026 (USD MILLION) 186

TABLE 240 INDIA: BREAST RECONSTRUCTION MARKET, BY TYPE,

2018–2020 (USD MILLION) 187

TABLE 241 INDIA: BREAST RECONSTRUCTION MARKET, BY TYPE,

2021–2026 (USD MILLION) 187

TABLE 242 INDIA: BREAST RECONSTRUCTION MARKET, BY END USER,

2018–2020 (USD MILLION) 187

TABLE 243 INDIA: BREAST RECONSTRUCTION MARKET, BY END USER,

2021–2026 (USD MILLION) 187

10.4.4 REST OF ASIA PACIFIC 188

TABLE 244 ROAPAC: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2018–2020 (USD MILLION) 188

TABLE 245 ROAPAC: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 188

TABLE 246 ROAPAC: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY TYPE, 2018–2020 (USD MILLION) 189

TABLE 247 ROAPAC: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY TYPE, 2021–2026 (USD MILLION) 189

TABLE 248 ROAPAC: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2018–2020 (USD MILLION) 189

TABLE 249 ROAPAC: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2021–2026 (USD MILLION) 190

TABLE 250 ROAPAC: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2018–2020 (USD MILLION) 190

TABLE 251 ROAPAC: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2021–2026 (USD MILLION) 190

TABLE 252 ROAPAC: BREAST RECONSTRUCTION MARKET, BY TYPE,

2018–2020 (USD MILLION) 191

TABLE 253 ROAPAC: BREAST RECONSTRUCTION MARKET, BY TYPE,

2021–2026 (USD MILLION) 191

TABLE 254 ROAPAC: BREAST RECONSTRUCTION MARKET, BY END USER,

2018–2020 (USD MILLION) 191

TABLE 255 ROAPAC: BREAST RECONSTRUCTION MARKET, BY END USER,

2021–2026 (USD MILLION) 191

10.5 REST OF THE WORLD 192

TABLE 256 ROW: BREAST CANCER INCIDENCE, BY COUNTRY, 2020 VS. 2040 192

TABLE 257 ROW: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2018–2020 (USD MILLION) 192

TABLE 258 ROW: BREAST RECONSTRUCTION MARKET, BY PRODUCT,

2021–2026 (USD MILLION) 192

TABLE 259 ROW: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION) 193

TABLE 260 ROW: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION) 193

TABLE 261 ROW: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2018–2020 (USD MILLION) 193

TABLE 262 ROW: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,

BY SHAPE, 2021–2026 (USD MILLION) 194

TABLE 263 ROW: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2018–2020 (USD MILLION) 194

TABLE 264 ROW: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,

2021–2026 (USD MILLION) 194

TABLE 265 ROW: BREAST RECONSTRUCTION MARKET, BY TYPE,

2018–2020 (USD MILLION) 195

TABLE 266 ROW: BREAST RECONSTRUCTION MARKET, BY TYPE,

2021–2026 (USD MILLION) 195

TABLE 267 ROW: BREAST RECONSTRUCTION MARKET, BY END USER,

2018–2020 (USD MILLION) 195

TABLE 268 ROW: BREAST RECONSTRUCTION MARKET, BY END USER,

2021–2026 (USD MILLION) 195

11 COMPETITIVE LANDSCAPE 196

11.1 OVERVIEW 196

11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 196

TABLE 269 OVERVIEW OF THE STRATEGIES ADOPTED BY KEY PLAYERS IN THE BREAST RECONSTRUCTION MARKET 196

11.3 REVENUE SHARE ANALYSIS 197

FIGURE 36 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN THE BREAST RECONSTRUCTION MARKET 198

11.4 MARKET SHARE ANALYSIS 198

FIGURE 37 BREAST RECONSTRUCTION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020 199

TABLE 270 BREAST RECONSTRUCTION MARKET: DEGREE OF COMPETITION 199

11.5 COMPETITIVE LEADERSHIP MAPPING 200

FIGURE 38 BREAST RECONSTRUCTION MARKET: COMPETITIVE

LEADERSHIP MAPPING (2020) 201

11.6 COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS 202

FIGURE 39 BREAST RECONSTRUCTION MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES & START-UPS (2020) 203

11.7 COMPANY FOOTPRINT 203

TABLE 271 COMPANY FOOTPRINT 204

TABLE 272 COMPANY PRODUCT FOOTPRINT 205

TABLE 273 COMPANY REGIONAL FOOTPRINT 206

11.8 COMPETITIVE BENCHMARKING 207

TABLE 274 BREAST RECONSTRUCTION MARKET: DETAILED LIST OF KEY START-UPS/SMES 207

11.9 COMPETITIVE SCENARIO 208

TABLE 275 KEY PRODUCT LAUNCHES & APPROVALS, JANUARY 2018– FEBRUARY 2022 208

TABLE 276 KEY DEALS, JANUARY 2018– FEBRUARY 2022 209

TABLE 277 OTHER KEY DEVELOPMENTS, JANUARY 2018– FEBRUARY 2022 210

12 COMPANY PROFILES 211

12.1 KEY PLAYERS 211

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*

12.1.1 MENTOR WORLDWIDE LLC (JOHNSON & JOHNSON) 211

TABLE 278 MENTOR WORLDWIDE LLC (JOHNSON & JOHNSON): BUSINESS OVERVIEW 211

FIGURE 40 MENTOR WORLDWIDE LLC (JOHNSON & JOHNSON): COMPANY SNAPSHOT (2020) 212

12.1.2 ALLERGAN AESTHETICS (AN ABBVIE COMPANY) 215

TABLE 279 ALLERGAN AESTHETICS (AN ABBVIE COMPANY): BUSINESS OVERVIEW 215

FIGURE 41 ALLERGAN AESTHETICS (AN ABBVIE COMPANY):

COMPANY SNAPSHOT (2020) 216

12.1.3 RECENT DEVELOPMENTS 217

12.1.4 SIENTRA 219

TABLE 280 SIENTRA: BUSINESS OVERVIEW 219

FIGURE 42 SIENTRA: COMPANY SNAPSHOT (2020) 220

12.1.5 POLYTECH HEALTH & AESTHETICS GMBH 223

TABLE 281 POLYTECH HEALTH & AESTHETICS: BUSINESS OVERVIEW 223

12.1.6 RECENT DEVELOPMENTS 224

12.1.7 GC AESTHETICS 226

TABLE 282 GC AESTHETICS: BUSINESS OVERVIEW 226

12.1.8 SEBBIN 227

TABLE 283 SEBBIN: BUSINESS OVERVIEW 227

12.1.9 ESTABLISHMENT LABS S.A. 228

TABLE 284 ESTABLISHMENT LABS HOLDINGS: BUSINESS OVERVIEW 228

FIGURE 43 ESTABLISHMENT LABS HOLDINGS: COMPANY SNAPSHOT (2020) 228

12.1.10 INTEGRA LIFESCIENCES 230

TABLE 285 INTEGRA LIFESCIENCES: BUSINESS OVERVIEW 230

FIGURE 44 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2020) 231

12.1.11 RTI SURGICAL HOLDINGS 233

TABLE 286 RTI SURGICAL HOLDINGS: BUSINESS OVERVIEW 233

FIGURE 45 RTI SURGICAL HOLDINGS: COMPANY SNAPSHOT (2018) 233

12.1.12 IDEAL IMPLANT INCORPORATED 235

TABLE 287 IDEAL IMPLANT INCORPORATED: BUSINESS OVERVIEW 235

12.1.13 LABORATORIES ARION 236

TABLE 288 LABORATORIES ARION: BUSINESS OVERVIEW 236

12.1.14 SILIMED 237

TABLE 289 SILIMED: BUSINESS OVERVIEW 237

12.1.15 GUANGZHOU WANHE PLASTIC MATERIALS CO. LTD. 238

TABLE 290 GUANGZHOU WANHE PLASTIC MATERIALS CO. LTD.: BUSINESS OVERVIEW 238

12.1.16 CEREPLAS 239

TABLE 291 CEREPLAS: BUSINESS OVERVIEW 239

12.1.17 HANSBIOMED 240

TABLE 292 HANSBIOMED: BUSINESS OVERVIEW 240

12.1.18 PRODUCTS OFFERED 240

12.2 OTHER PLAYERS 242

12.2.1 SHANGHAI KANGNING MEDICAL DEVICE 242

12.2.2 PMT CORPORATION 242

12.2.3 PFM MEDICAL 243

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX 244

13.1 DISCUSSION GUIDE 244

13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 249

13.3 AVAILABLE CUSTOMIZATIONS 251

13.4 RELATED REPORTS 251

13.5 AUTHOR DETAILS 252

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（在宅・地域医療）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（hospitals）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

乳房再建市場：製品（乳房インプラント、Tissue Expander、Acellular Dermal Matrix）、施術（即時、遅延、修正）、タイプ（片側、両側）、エンドユーザー（病院、美容クリニック）別 - 2026年までの世界市場予測

サマリー

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（在宅・地域医療）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（hospitals）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?